Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
0.970
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Enzo Biochem Balance Sheet
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 52.37 | 52.37 | 82.37 | 21.6 | 13.52 | 47.87 | Upgrade
|
Short-Term Investments | - | - | - | - | 29.98 | - | Upgrade
|
Cash & Short-Term Investments | 52.37 | 52.37 | 82.37 | 21.6 | 43.5 | 47.87 | Upgrade
|
Cash Growth | -36.42% | -36.42% | 281.30% | -50.34% | -9.12% | -20.42% | Upgrade
|
Receivables | 3.99 | 3.99 | 4.81 | 4.76 | 10.2 | 9.14 | Upgrade
|
Inventory | 6.83 | 6.83 | 7.94 | 9.52 | 12.65 | 7.78 | Upgrade
|
Prepaid Expenses | 1.84 | 1.84 | 2.34 | 2.82 | 4.23 | 3.98 | Upgrade
|
Restricted Cash | 5 | 5 | 1 | - | - | - | Upgrade
|
Other Current Assets | - | - | - | 4.13 | - | - | Upgrade
|
Total Current Assets | 70.03 | 70.03 | 98.46 | 42.82 | 70.58 | 68.77 | Upgrade
|
Property, Plant & Equipment | 15.2 | 15.2 | 16.71 | 16.02 | 33.61 | 34.4 | Upgrade
|
Goodwill | - | - | - | - | 7.45 | 7.45 | Upgrade
|
Other Intangible Assets | - | - | - | - | 0.24 | 0.54 | Upgrade
|
Other Long-Term Assets | 0.53 | 0.53 | 6.71 | 16.77 | 1.81 | 1.39 | Upgrade
|
Total Assets | 85.76 | 85.76 | 121.88 | 75.61 | 113.69 | 112.54 | Upgrade
|
Accounts Payable | 1.38 | 1.38 | 3.58 | 3.72 | 8.12 | 8.5 | Upgrade
|
Accrued Expenses | 5.71 | 5.71 | 11.74 | 8.18 | 11.63 | 10.31 | Upgrade
|
Short-Term Debt | - | - | 2.51 | - | - | 7 | Upgrade
|
Current Portion of Long-Term Debt | 0.08 | 0.08 | 0.08 | 0.23 | 0.15 | 0.14 | Upgrade
|
Current Portion of Leases | 0.84 | 0.84 | 0.98 | 0.9 | 3.5 | 4.33 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 2.68 | 2.53 | Upgrade
|
Other Current Liabilities | 16.79 | 16.79 | 21.1 | - | - | - | Upgrade
|
Total Current Liabilities | 24.79 | 24.79 | 39.99 | 13.02 | 26.08 | 32.8 | Upgrade
|
Long-Term Debt | 0.19 | 0.19 | 0.27 | 4.08 | 4.36 | 4.49 | Upgrade
|
Long-Term Leases | 2.4 | 2.4 | 3.16 | 4.05 | 14.67 | 16.84 | Upgrade
|
Other Long-Term Liabilities | 2.27 | 2.27 | - | - | 0.01 | 0.03 | Upgrade
|
Total Liabilities | 29.65 | 29.65 | 43.42 | 21.15 | 45.11 | 54.16 | Upgrade
|
Common Stock | 0.52 | 0.52 | 0.5 | 0.49 | 0.49 | 0.48 | Upgrade
|
Additional Paid-In Capital | 348.13 | 348.13 | 344.44 | 339.46 | 337.13 | 334.47 | Upgrade
|
Retained Earnings | -294.43 | -294.43 | -268.35 | -288.64 | -270.38 | -278.25 | Upgrade
|
Comprehensive Income & Other | 1.89 | 1.89 | 1.88 | 3.15 | 1.35 | 1.68 | Upgrade
|
Shareholders' Equity | 56.11 | 56.11 | 78.46 | 54.46 | 68.59 | 58.38 | Upgrade
|
Total Liabilities & Equity | 85.76 | 85.76 | 121.88 | 75.61 | 113.69 | 112.54 | Upgrade
|
Total Debt | 3.51 | 3.51 | 7 | 9.26 | 22.68 | 32.79 | Upgrade
|
Net Cash (Debt) | 48.86 | 48.86 | 75.38 | 12.35 | 20.83 | 15.08 | Upgrade
|
Net Cash Growth | -35.17% | -35.17% | 510.42% | -40.71% | 38.15% | -72.67% | Upgrade
|
Net Cash Per Share | 0.96 | 0.96 | 1.53 | 0.25 | 0.43 | 0.32 | Upgrade
|
Filing Date Shares Outstanding | 52.24 | 52.24 | 50.49 | 48.72 | 48.47 | 47.9 | Upgrade
|
Total Common Shares Outstanding | 52.24 | 52.24 | 50 | 48.72 | 48.47 | 47.9 | Upgrade
|
Working Capital | 45.24 | 45.24 | 58.47 | 29.8 | 44.51 | 35.96 | Upgrade
|
Book Value Per Share | 1.07 | 1.07 | 1.57 | 1.12 | 1.41 | 1.22 | Upgrade
|
Tangible Book Value | 56.11 | 56.11 | 78.46 | 54.46 | 60.89 | 50.39 | Upgrade
|
Tangible Book Value Per Share | 1.07 | 1.07 | 1.57 | 1.12 | 1.26 | 1.05 | Upgrade
|
Land | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | Upgrade
|
Buildings | 11.7 | 11.7 | 12.5 | 11.82 | 10.31 | 10.09 | Upgrade
|
Machinery | 14.36 | 14.36 | 14.92 | 13.24 | 27.32 | 23.74 | Upgrade
|
Leasehold Improvements | 1.04 | 1.04 | 0.89 | 0.65 | 5.69 | 5.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.